Tumor therapy has evolved significantly over recent decades, yet tumors continue to develop resistance to conventional ...

Glioblastoma (GBM) is a deadly tumor of the central nervous system (CNS) having a dismal prognosis. miRNA-based therapeutics hold immense potential for GBM therapy; however, its delivery remains a ...

In prior studies, an antiangiogenic profile has been associated with higher rates of failure to IMM in stroke. The purpose of this study is to evaluate the hypothesis that aging is an independent ...

206Background: Anti-angiogenic drugs represent a cornerstone of metastatic colorectal cancer (mCRC) patients (pts) treatment. Currently, no prognostic/predictive biomarkers were validated to identify ...

Antiangiogenic Therapy Escape A retrospective analysis in patients with malignant glioma who were treated with a second-line regimen containing bevacizumab after failure of treatment with an ...

These findings underscore the importance of biomarkers that would predict whether a patient will respond to, and monitor the efficacy of or the resistance to, antiangiogenic therapy.

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s Enflonsia.

Combined antifibrotic and pulmonary vasodilator therapy may help transplant-free survival in patients with PH associated with pulmonary fibrosis.

Keywords: immunochemotherapy, anti-angiogenic therapy, Survival, pulmonary large-cell neuroendocrine carcinoma, case report Received: 26 Apr 2025; Accepted: 16 Jun 2025.

Neuropilin-1 (Nrp1), an essential type I transmembrane receptor, binds two secreted ligand families, vascular endothelial growth factor (VEGF) and class III Semaphorin (Sema3). VEGF-A and Sema3F have ...

Alsheebani is one of the first adults in the world, and the first adult at the medical system, to be effectively cured of sickle cell disease using gene therapy.